Evidence map›Paper›PMID 36550367›Full record

ArticleCommunications biology2022

Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays.

Ehsan Manouchehri Doulabi, Claudia Fredolini, Radiosa Gallini, Liza Löf, Qiujin Shen, Ryoyo Ikebuchi, Louise Dubois, Alireza Azimi, Olivier Loudig, Susanne Gabrielsson and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06798558 (Phase II Study of Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06798558 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Phase II Study of Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

TypeinterventionalSponsorHackensack Meridian HealthRan2025 to 2029Enrolled54ConditionsProstate AdenocarcinomaArmsLu-17-PSMA-617
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Ehsan Manouchehri Doulabi *Department of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-1639-2267
Claudia Fredolini *Department of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Radiosa GalliniDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-2709-3337
Liza LöfDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Qiujin ShenDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Ryoyo IkebuchiDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Louise DuboisDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Alireza AzimiDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Olivier LoudigCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA.
Susanne GabrielssonDivision of Immunology and Allergy, Department of Medicine, Karolinska Institutet, Solna, Sweden.ORCID 0000-0003-1771-1346
Ulf LandegrenDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-7820-1000
Anders LarssonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-3161-0402
Jonas BergquistDepartment of Chemistry-BMC, Analytical Chemistry, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-4597-041X
Masood Kamali-MoghaddamDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. masood.kamali@igp.uu.se.ORCID 0000-0002-1303-2218
Uppsala University · SEHackensack Meridian Health · USKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) are mediators of intercellular communication and a promising class of biomarkers. Surface proteins of EVs play decisive roles in establishing a connection with recipient cells, and they are putative targets for diagnostic assays. Analysis of the surface proteins can thus both illuminate the biological functions of EVs and help identify potential biomarkers. We developed a strategy combining high-resolution mass spectrometry (HRMS) and  proximity ligation assays (PLA) to first identify and then validate surface proteins discovered on EVs. We applied our workflow to investigate surface proteins of small EVs found in seminal fluid (SF-sEV). We identified 1,014 surface proteins and verified the presence of a subset of these on the surface of SF-sEVs. Our work demonstrates a general strategy for deep analysis of EVs' surface proteins across patients and pathological conditions, proceeding from unbiased screening by HRMS to ultra-sensitive targeted analyses via PLA.

Indexed as

Extracellular VesiclesProstateBiomarkersHumansMaleMass SpectrometryMembrane ProteinsBiomarkersMembrane Proteins

Identifiers

PMID36550367
PMCPMC9780212
OpenAlexW4312193174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.